Photocure ASA: Annual Report 2024

11 Apr 2025 15:20 CEST

Oslo, Norway, 11 April 2024: Photocure ASA today announces the publication of
the Annual Report and integrated ESG report for 2024.

The Board of Directors of Photocure ASA has approved the annual accounts for
2024. The financial statements and annual report for the financial year 2024 are
together with the ESG report and auditor's report attached to this notice. The
ESEF file for 2024 is also attached.

The documents are enclosed and also made available at the company's website
under https://photocure.com/investors-hub/investors-events-and-presentations.

For further information, please contact:

Erik Dahl

CFO
Photocure ASA
Tel: +4745055000
Email: ed@photocure.com

About Photocure ASA

The Bladder Cancer Company delivers transformative solutions to improve the
lives of bladder cancer patients. Our unique technology, making cancer cells
glow bright pink, has led to better health outcomes for patients worldwide.
Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock
Exchange (OSE: PHO). For more information, please visit us at www.photocure.com
and www.cysview.com.

All trademarks mentioned in this release are protected by law and are registered
trademarks of Photocure ASA. This information is subject to the disclosure
requirements pursuant to sections 5-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

643654_Photocure_Annual_Report_and_ESG_2024.pdf
643654_Release.pdf
643654_5967007LIEEXZXG8OW35_2024_12_31_en.zip